COH.AU Cochlear Ltd

Healthcare Health Care Equipment & Supplies Australian Securities Exchange
143.64 AUD
Close of Nov 1, 2026
87.88 284.78
Market cap
AUD 9.39B
P/E
63.8x
P/B
5.40x
ROE
8.5%
Dividend yield
2.99%
Fundamental score
2.5/5

Ratios use the latest price and the fiscal year ending Jun 2026.

Is COH.AU undervalued?

Graham number

The Graham number of Cochlear Ltd cannot be estimated reliably (the estimate is too far from the market price).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Cochlear Ltd fundamental analysis

12 of 22 checks passed

ROE 0/2

Low return on equity (8.5%), below 10%.

ROA 1/1

Return on assets (5.7%) is above the industry median (-35.3%).

Profit Consistency 2/2

Profitable for 6 consecutive years.

Earnings Growth 5Y 0/1

Earnings per share did not grow over the past 5 years.

Earnings Acceleration 0/1

Last year's EPS growth (-62.2%) is not above the 5-year average (-14.7% a year).

Earnings Growth vs Industry 0/1

Last year's EPS growth (-62.2%) is below the industry median (24.9%).

Revenue Growth 1/2

Revenue grew 6.4% a year over the past 3 years.

Short-term Liquidity 1/1

Current assets cover short-term liabilities.

Long-term Liabilities 1/1

Current assets cover long-term liabilities.

Debt to Equity 2/2

Low debt to equity (12.2%), 40% or less.

Debt Trend 1/1

Debt to equity has not risen over the past 5 years.

Debt Coverage 1/1

Operating cash flow covers 20% of total debt.

Interest Coverage 1/1

EBIT is 22.8x against interest expense, well covered.

PE vs Market 0/1

PE (63.8x) is above the market median (15.0x).

PE vs Industry 0/1

PE (63.8x) is above the industry median (36.4x).

PBV 0/1

Price to book (5.4x) is above the industry median (4.0x).

Graham Number 0/1

The price is above the Graham number (PE x PB = 344.6, limit 22.5).

PEG 0/1

PEG needs positive PE and positive 5-year earnings growth.

Dividend Yield 1/2

Dividend yield (3.0%) is above the bottom 25% of dividend payers in the market.

Dividend Stability 1/2

Dividends paid without a cut of more than 10% for 6 years.

Dividend Growth 1/1

Dividends paid grew over the past 5 years.

Payout Ratio 0/1

Payout ratio is 190.9%, above 90% of earnings.

Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score

Cochlear Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Cochlear Ltd

Cochlear Limited provides implantable hearing solutions in the Americas, Europe, the Middle East, Africa, and Asia Pacific. It offers cochlear implant systems; replacement sound processors, accessories, and other services; bone conduction systems and replacement sound processors; and recipient support tools. The company also provides Cochlear connected care solutions, such as Cochlear Nucleus SmartNav System; Cochlear Custom Sound Pro Fitting Software; Cochlear Remote Assist…

Full company profile